Resource

A prospective trial of U500 insulin delivered by Omnipod in patients with type 2 diabetes mellitus and severe insulin resistance.

Lane, Wendy S; Weinrib, Stephen L; Rappaport, Jonathan M; Przestrzelski, Therese
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists; 16(5):778-84. PMID: 20350913
Category: 
Interventions
Links: 
PubMed Article
Journal Article

Abstract

To test the effectiveness and safety of U500 regular insulin delivered by continuous subcutaneous insulin infusion (CSII) via the Omnipod insulin delivery system in patients with uncontrolled type 2 diabetes mellitus and severe insulin resistance.